首页>
外国专利>
COMBINATION THERAPY FOR THE TREATMENT OF CD19+ B-CELL MALIGNANCIES SYMPTOMS COMPRISING AN ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE AND RITUXIMAB
COMBINATION THERAPY FOR THE TREATMENT OF CD19+ B-CELL MALIGNANCIES SYMPTOMS COMPRISING AN ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE AND RITUXIMAB
展开▼
机译:联合疗法治疗包含抗CD19蛋黄质免疫偶联物和利妥昔单抗的CD19 + B细胞恶性肿瘤症状
展开▼
页面导航
摘要
著录项
相似文献
摘要
A combination of an anti-CD19 maytansinoid immunoconjugate and rituximab is used for treating CD19+ CD20+ B-cell malignancies symptom, in particular Non-Hodgkin's lymphoma.
展开▼